{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T20:06:12Z","timestamp":1760299572584},"reference-count":0,"publisher":"Harborside Press, LLC","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Natl Compr Canc Netw"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.6004\/jnccn.2016.0016","type":"journal-article","created":{"date-parts":[[2017,4,14]],"date-time":"2017-04-14T16:07:51Z","timestamp":1492186071000},"page":"128-131","source":"Crossref","is-referenced-by-count":6,"title":["What Happens When Imatinib Goes Generic?"],"prefix":"10.6004","volume":"14","author":[{"given":"Jean","family":"McDougall","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott D.","family":"Ramsey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerald","family":"Radich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4047","published-online":{"date-parts":[[2016,2,5]]},"container-title":["Journal of the National Comprehensive Cancer Network"],"original-title":[],"language":"en","deposited":{"date-parts":[[2019,3,4]],"date-time":"2019-03-04T17:12:29Z","timestamp":1551719549000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnccn.org\/doi\/10.6004\/jnccn.2016.0016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":0,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2016,2,5]]},"published-print":{"date-parts":[[2016,2]]}},"alternative-id":["10.6004\/jnccn.2016.0016"],"URL":"https:\/\/doi.org\/10.6004\/jnccn.2016.0016","relation":{},"ISSN":["1540-1405","1540-1413"],"issn-type":[{"value":"1540-1405","type":"print"},{"value":"1540-1413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2]]}}}